Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locoregionally Advanced Nasopharyngeal Carcinoma”

89 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 89 results

Not applicableLooking for participantsNCT05717790
What this trial is testing

Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma by AJCC V8 Stage
Fourth Affiliated Hospital of Guangxi Medical University 288
Testing effectiveness (Phase 2)Active Not RecruitingNCT05340270
What this trial is testing

PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNeoadjuvant TherapyPD-1 Inhibitor
Guangxi Medical University 150
Testing effectiveness (Phase 2)Study completedNCT02794077
What this trial is testing

Cyclophosphamide for Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Undifferentiated CarcinomaStage IV Nasopharyngeal Undifferentiated Carcinoma
The University of Hong Kong 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT03047265
What this trial is testing

Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 164
Testing effectiveness (Phase 2)Active Not RecruitingNCT05193617
What this trial is testing

Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 104
Large-scale testing (Phase 3)UnknownNCT03366415
What this trial is testing

Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC

Who this might be right for
Nasopharyngeal Carcinoma
Chaosu Hu 420
Not applicableUnknownNCT02096380
What this trial is testing

The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
First People's Hospital of Foshan 120
Large-scale testing (Phase 3)Active Not RecruitingNCT02460887
What this trial is testing

The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 236
Large-scale testing (Phase 3)Active Not RecruitingNCT04907370
What this trial is testing

PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 532
Testing effectiveness (Phase 2)UnknownNCT03058432
What this trial is testing

Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 122
Large-scale testing (Phase 3)UnknownNCT03427827
What this trial is testing

PD-1 Antibody Versus Best Supportive Care After Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 450
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07064902
What this trial is testing

Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 48
Large-scale testing (Phase 3)Active Not RecruitingNCT05587374
What this trial is testing

Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal Cancer
Sun Yat-sen University 490
Large-scale testing (Phase 3)Not Yet RecruitingNCT06900218
What this trial is testing

PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 664
Testing effectiveness (Phase 2)Study completedNCT03025958
What this trial is testing

Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07385079
What this trial is testing

Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharyngeal Cancer
Sun Yat-sen University 412
Large-scale testing (Phase 3)UnknownNCT03700476
What this trial is testing

Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 425
Large-scale testing (Phase 3)UnknownNCT00705627
What this trial is testing

Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 400
Testing effectiveness (Phase 2)Looking for participantsNCT06349889
What this trial is testing

Adebrelimab and Chemoradiotherapy in High-risk LANPC

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal Cancer
Sun Yat-sen University 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07238569
What this trial is testing

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharangeal Cancer
Sun Yat-sen University 516
Next Page